The slip
PARKINSON RECEIPTno. 0105
16 Oct 2026, 16:40 UTCdopamine neurons, braak
predictionNDUFAB1 in dopamine neurons tracks Braak Lewy-body stage
registeredd6737818411a5a18
discovery+0.06 p=0.713 n=42
replication-0.02 p=0.914 n=42
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.06, p 0.713)
datasimulated substantia nigra cohort (84 donors)
NO EFFECT233f93e7302897c4231bda2f…
follows a8c78709419d…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0105: NDUFAB1 in dopamine neurons, braak
- power
- full sample +0.03 (p 0.795, n 84), 95% CI -0.19 to +0.24. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: +0.01 (p 0.952, n 84). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis -0.72 (p 1.8e-14); controlling for it: +0.03 (p 0.752, n 84). could be the mix.
- skeptic
- leave-one-out range -0.01 to +0.06, sign flips 3; without severely affected donors +0.03 (p 0.806, n 75). fragile.
- cell type
- strongest in oligodendrocytes: +0.35 (p 0.0013, n 84) vs +0.03 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NDUFAB1 in dopamine neurons.
follow-up registered; not confirmed in ventral tegmental area.
follow-up NDUFAB1 · oligodendrocytes · braak: ventral tegmental area +0.25 p 0.026 (needs p < 0.0033)